Dario Roccatello, Savino Sciascia, Daniela Rossi, Roberta Fenoglio. Targeting CD38 Across Autoimmune and Plasma Cell–Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape. // BioDrugs. – 2026. – DOI: 10.1007/s40259-026-00799-5. – URL: https://doi.org/10.1007/s40259-026-00799-5
Dario Roccatello, Savino Sciascia, Daniela Rossi, & Roberta Fenoglio (2026). Targeting CD38 Across Autoimmune and Plasma Cell–Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape. BioDrugs. https://doi.org/10.1007/s40259-026-00799-5
Dario Roccatello, et al. “Targeting CD38 Across Autoimmune and Plasma Cell–Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape.” BioDrugs, 2026. doi:10.1007/s40259-026-00799-5.
@article{Roccatello2026,
title = {Targeting CD38 Across Autoimmune and Plasma Cell–Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape},
author = {Roccatello, Dario and Sciascia, Savino and Rossi, Daniela and Fenoglio, Roberta},
journal = {BioDrugs},
year = {2026},
doi = {10.1007/s40259-026-00799-5},
url = {https://doi.org/10.1007/s40259-026-00799-5}
}